| __timestamp | Dr. Reddy's Laboratories Limited | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 38783000000 | 504755000 |
| Thursday, January 1, 2015 | 42585000000 | 838526000 |
| Friday, January 1, 2016 | 45702000000 | 1177697000 |
| Sunday, January 1, 2017 | 46372000000 | 1320433000 |
| Monday, January 1, 2018 | 46910000000 | 1556200000 |
| Tuesday, January 1, 2019 | 48890000000 | 1834800000 |
| Wednesday, January 1, 2020 | 50129000000 | 1346000000 |
| Friday, January 1, 2021 | 54559000000 | 1824900000 |
| Saturday, January 1, 2022 | 62081000000 | 2115900000 |
| Sunday, January 1, 2023 | 105931000000 | 2631300000 |
| Monday, January 1, 2024 | 77201000000 | 2954400000 |
In pursuit of knowledge
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Over the past decade, Regeneron Pharmaceuticals, Inc. and Dr. Reddy's Laboratories Limited have showcased contrasting strategies in this domain. From 2014 to 2023, Dr. Reddy's Laboratories consistently reported higher SG&A expenses, peaking at approximately 106% more than Regeneron in 2023. This trend suggests a more aggressive investment in administrative and sales functions. In contrast, Regeneron maintained a leaner approach, with expenses growing steadily but remaining significantly lower. Notably, Dr. Reddy's saw a dramatic spike in 2023, while Regeneron's data for 2024 remains unavailable, leaving room for speculation. As these companies navigate the ever-evolving pharmaceutical landscape, their SG&A strategies will continue to play a pivotal role in their financial health and market positioning.
Cost Management Insights: SG&A Expenses for AbbVie Inc. and Dr. Reddy's Laboratories Limited
Pfizer Inc. or Regeneron Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Regeneron Pharmaceuticals, Inc. or Viatris Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Regeneron Pharmaceuticals, Inc. and Exelixis, Inc.
Breaking Down SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Apellis Pharmaceuticals, Inc.
Comparing SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs MorphoSys AG Trends and Insights
Regeneron Pharmaceuticals, Inc. or Ligand Pharmaceuticals Incorporated: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Novavax, Inc.
Cost Management Insights: SG&A Expenses for Dr. Reddy's Laboratories Limited and Apellis Pharmaceuticals, Inc.
Comparing SG&A Expenses: Dr. Reddy's Laboratories Limited vs Soleno Therapeutics, Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing Dr. Reddy's Laboratories Limited and Agios Pharmaceuticals, Inc.
Dr. Reddy's Laboratories Limited or Supernus Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?